spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  heparin 

 HSMN NewsFeed - 18 Jul 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 23 Jun 2021
Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 May 2021
Perosphere Technologies Announces CE-IVD Marking of the Perosphere Technologies PoC Coagulometer System for DOAC and Heparin Testing
Devices Diagnostics Regulatory
 HSMN NewsFeed - 15 Apr 2021
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 9 Dec 2020
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Oct 2019
Fresenius Medical Care Receives FDA Breakthrough Device Designation for New Dialysis System to Prevent Blood Clotting Without the Use of Blood Thinners
Devices FDA
 HSMN NewsFeed - 13 Mar 2019
FDA Grants De Novo for the HemoSonics Quantra(R) QPlus System; This Revolutionary Diagnostic Provides Unique Information for Accessing Coagulation at the Point of Care; Now Commercially Available in US
Devices Diagnostics FDA
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2016
Study Published in Journal of Glaucoma Evaluates a Single Glaukos iStent(R) Trabecular Micro-Bypass Stent as a Standalone Procedure
Devices Ophthalmology
 HSMN NewsFeed - 24 Nov 2016
Kymab Secures US$100 Million Series C Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Sep 2016
FDA Approves New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 Aug 2016
GORE(R) TIGRIS(R) Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 28 Jun 2016
GORE(R) VIABAHN(R) Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases
Devices Interventional
 HSMN NewsFeed - 27 May 2016
Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2016
Medicure Files Application for New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Mar 2016
Glaukos iStent(R) Trabecular Micro-Bypass Stent Approved in Japan
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Nov 2015
Akers Biosciences Appoints Medical Technology Specialist as CEO
Diagnostics Personnel
 HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 2 Apr 2015
Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jan 2015
Akers Expands U.S. Sales Efforts With Key Leadership Additions
Diagnostics Personnel
 HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 10 Dec 2014
Gore Receives CE Mark Approval for GORE(R) VIABAHN(R) Endoprosthesis for Revision of Arteriovenous Access
Devices Regulatory
 HSMN NewsFeed - 5 Aug 2014
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
Diagnostics Personnel
 HSMN NewsFeed - 21 Jul 2014
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
Devices Group Purchasing
 HSMN NewsFeed - 15 Jul 2014
Pradaxa(R) (dabigatran etexilate) Now Available in the UK for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and Prevention of Recurrence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2014
Akers Biosciences Signs Agreement With Medline -- a Major US Distributor
Diagnostics Distribution
 HSMN NewsFeed - 23 May 2014
EkoSonic(R) Endovascular System Receives FDA Clearance for the Treatment of Pulmonary Embolism in the USA
Devices Interventional FDA
 HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 7 Mar 2014
AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Feb 2014
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
Devices
 HSMN NewsFeed - 13 Feb 2014
Excelsior Medical Files Patent Infringement Suit Against Ivera Medical
Devices Litigation
 HSMN NewsFeed - 20 Jan 2014
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association’s Journal, Circulation
Devices Interventional
 HSMN NewsFeed - 6 Nov 2013
Gore Receives FDA Approval for 25 cm GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional
 HSMN NewsFeed - 3 Oct 2013
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
Devices
 HSMN NewsFeed - 12 Sep 2013
First Patient Enrolled in Gore SCAFFOLD Clinical Study for Carotid Stenting
Devices Interventional
 HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Aug 2013
FDA Accepts Boehringer Ingelheim's Supplemental New Drug Application for Use of Dabigatran Etexilate Mesylate in Deep Vein Thrombosis and Pulmonary Embolism
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2013
AngioDynamics Earns FDA Clearance for Ports With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 27 Jun 2013
AngioDynamics Announces FDA Clearance for Xcela Plus Port Family With PASV Technology
Devices FDA
 HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 14 Nov 2012
New 10 cm GORE(R) Hybrid Vascular Graft Delivers Unprecedented Versatility
Devices Interventional
 HSMN NewsFeed - 7 Nov 2012
URGENT NOTICE -- DRUG RECALL: Boehringer Ingelheim Pharmaceuticals, Inc. Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa(R) (dabigatran etexilate mesylate) Capsules 75mg in the U.S. and Puerto Rico
Biopharmaceuticals Cardiology Product Recall
 HSMN NewsFeed - 29 Aug 2012
AngioDynamics Earns FDA Clearance for First Vascular Access Product With BioFlo Technology to Reduce Catheter-Related Thrombus
Devices FDA
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Aug 2012
Gore Receives CE Mark for GORE(R) Hybrid Vascular Graft
Devices Interventional Regulatory
 HSMN NewsFeed - 10 Jul 2012
Spiral Flow Grafts Enhance Treatment for Patients with Peripheral Artery Disease
Devices
 HSMN NewsFeed - 6 Jul 2012
Spiral Flow(TM) Grafts Enhance Patient Outcomes - New Paper Published in the Prestigious 'Annals of Vascular Surgery'
Devices
 HSMN NewsFeed - 30 Jan 2012
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery
Devices Surgery FDA
 HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2011
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
Devices Monitoring Regulatory
 HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Jun 2011
GORE(R) Hybrid Vascular Graft Commercially Available in the United States
Devices
 HSMN NewsFeed - 19 May 2011
MAQUET Cardiovascular Receives 510(k) Clearance to Market CARDIOROOT Aortic Graft in U.S.
Devices FDA
 HSMN NewsFeed - 19 May 2011
MAQUET Cardiovascular Receives European CE Mark for CARDIOROOT Aortic Graft
Devices Regulatory
 HSMN NewsFeed - 18 May 2011
Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN(R) Device
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2011
Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA(R) (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
Biopharmaceuticals Surgery Regulatory
 HSMN NewsFeed - 21 Mar 2011
Gore Reports First Patient Treated in the United States using GORE(R) VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System
Devices Interventional
 HSMN NewsFeed - 16 Mar 2011
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
Devices Regulatory
 HSMN NewsFeed - 22 Feb 2011
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
Devices Regulatory
 HSMN NewsFeed - 17 Feb 2011
Gore Announces FDA Approval of Next Evolution of GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 19 Jan 2011
Gore Announces European Availability of Next Evolution of GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional
 HSMN NewsFeed - 10 Jan 2011
Interface Biologics Announces $7M Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA
 HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2010
First European Patients Treated for Peripheral Artery Disease Using Longest Length GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional
 HSMN NewsFeed - 12 Aug 2010
First Patient Implanted in Investigational Study for Self Sealing GORE(R) ACUSEAL Vascular Graft
Devices
 HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2010
MAQUET Cardiovascular to Distribute INTERGARD Line of Vascular Grafts in United States
Devices Distribution
 HSMN NewsFeed - 1 Jul 2010
FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2010
Gore Receives CE Mark for Longer Length GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional Regulatory
 HSMN NewsFeed - 21 Jun 2010
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 14 Jun 2010
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 1 Jun 2010
CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation Testing System for Patient Home Use
Devices Diagnostics Monitoring FDA
 HSMN NewsFeed - 15 Apr 2010
Comparative Trial of Canyon's Iprivask(R) (Desirudin) with Standard of Care Shows Favorable Outcomes for Thrombosis Prophylaxis in Surgery Patients with HIT
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2010
Portola Pharmaceuticals Announces Senior Management and Board Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2009
Gore Expands Line of GORE PROPATEN(R) Vascular Grafts
Devices Interventional
 HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 16 Oct 2009
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Oct 2009
Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
Devices Personnel
 HSMN NewsFeed - 24 Sep 2009
MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
Devices Surgery Cardiology
 HSMN NewsFeed - 31 Aug 2009
Hospira Receives FDA Approval for Six New Presentations of Heparin
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Aug 2009
sanofi-aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Aug 2009
Real-World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin (UFH)
Biopharmaceuticals
 HSMN NewsFeed - 21 Jul 2009
Gore Receives FDA Approval for Next Generation of Large Diameter GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface
Devices Interventional FDA
 HSMN NewsFeed - 30 Jun 2009
Gore Receives FDA Approval for Modification of GORE VIABAHN® Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Jun 2009
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
Devices Distribution
 HSMN NewsFeed - 8 Jun 2009
Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
Devices Cardiology
 HSMN NewsFeed - 19 May 2009
Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
Devices Interventional FDA
 HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 1 May 2009
Excelsior Medical Corporation Receives FDA Approval to Market SwabCap(TM) Luer Access Valve Disinfection Cap
Devices FDA
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 14 Oct 2008
Baxa Ltd Launches ZR(R) Pre-Filled Saline Flush Syringes
Devices
 HSMN NewsFeed - 25 Sep 2008
Sagent Pharmaceuticals Acquires Rights to Multi-Chamber Syringe Technology and Launches Device Division
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2008
Gore Announces Broadened FDA Indication for GORE VIABAHN(R) Endoprosthesis for Iliac Occlusive Disease
Devices Interventional FDA
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Aug 2008
Medegen Grows Product Distribution Via Co-Marketing Agreement with Bard
Devices
 HSMN NewsFeed - 25 Jul 2008
PolyMedix Appoints Two New Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory
 HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 May 2008
Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery
Devices Product Recall
 HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2008
Gore Announces First Patient Enrolled in PRODIGY Study
Devices
 HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Mar 2008
U.S. Army Study Reports WoundStat(TM) is Most Effective
Devices Wound Care
 HSMN NewsFeed - 10 Mar 2008
Medegen Introduces MaxPlus(R) Clear, First and Only Clear Positive Displacement Connector for Use in Infusion Therapy
Devices
 HSMN NewsFeed - 28 Feb 2008
Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 25 Feb 2008
First Patient Enrolled in Study Evaluating Performance of Spectranetics Laser Ablation Followed by GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface
Devices Interventional
 HSMN NewsFeed - 15 Feb 2008
Keryx Biopharmaceuticals Announces Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2008
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
Devices Personnel
 HSMN NewsFeed - 11 Feb 2008
Baxter Provides Update on Heparin Reactions
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 11 Feb 2008
Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 29 Jan 2008
PolyMedix Appoints Brian Anderson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2008
Clexane(R)/Lovenox(R) Approved in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jan 2008
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Biopharmaceuticals Devices
 HSMN NewsFeed - 2 Jan 2008
VIBRANT Study of GORE VIABAHN(R) Endoprosthesis Completes Enrollment
Devices Interventional
 HSMN NewsFeed - 2 Jan 2008
Barr Confirms Patent Challenge of Argatroban(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Dec 2007
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
Biopharmaceuticals Litigation
 HSMN NewsFeed - 11 Dec 2007
W. L. GORE & ASSOCIATES ANNOUNCES SUMMARY OF GORE PROPATEN VASCULAR GRAFT STUDY DATA PRESENTED AT 34TH ANNUAL VEITHSYMPOSIUM™
Devices Interventional
 HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Nov 2007
PolyMedix Appoints Vice President of Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Oct 2007
First Patient Enrolled in Study of the GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface for Lower Limb Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 26 Sep 2007
Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 Sep 2007
Arbios Systems Publishes Positive Results From Completed Sepet(TM) Feasibility Clinical Trial
Devices
 HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 25 Jul 2007
NMT Medical Announces the Commercial Launch of BioSTAR(R) in Europe and Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2007
Gore REVISE Study Receives Conditional Approval from FDA
Devices Interventional FDA
 HSMN NewsFeed - 8 Jul 2007
New Study Shows That Extending Prophylaxis With Clexane(R) / Lovenox(R) (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Biopharmaceuticals
 HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Jun 2007
Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstrom's Macroglobulinemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
NMT Medical Receives CE Mark Approval for BioSTAR(R)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Devices Regenerative Medicine
 HSMN NewsFeed - 18 Jun 2007
NMT Medical's BioSTAR(R) Receives Canadian Regulatory Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Jun 2007
Keryx Biopharmaceuticals Announces Financial Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2007
Emisphere Technologies, Inc. Appoints Laura Kragie as Vice President of Clinical Development/Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 11 Jun 2007
Gore AVIATOR Study Receives Conditional Approval from FDA
Devices Interventional FDA
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 May 2007
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2007
Keryx Biopharmaceuticals Names Beth F. Levine as Senior Vice President, General Counsel & Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2007
The Lancet Publishes PREVAIL Study Results Showing Lovenox(R) Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2007
IBEX Partner Garvinci Inc. Acquires Additional Product Rights
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 31 Mar 2007
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Mar 2007
Data Shows That Omission of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Medical Patients Is Frequent and Leads to Higher Risk of Deep-Vein Thrombosis (DVT)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Feb 2007
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Feb 2007
New CoaguChek XS System Offers Healthcare Providers Greater Flexibility and Control for Anticoagulation Monitoring at the Point of Care
Diagnostics
 HSMN NewsFeed - 16 Jan 2007
Emisphere Announces Executive Management Changes
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Jan 2007
ATryn(R) Market Authorization Transferred To LEO Pharma A/S
Biopharmaceuticals
 HSMN NewsFeed - 28 Dec 2006
The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Dec 2006
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
Devices Cardiology FDA
 HSMN NewsFeed - 12 Dec 2006
New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
New Study Shows Lovenox(R) (Enoxaparin Sodium Injection) Is More Effective Than Unfractionated Heparin (UFH) for Lowering the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2006
Positive Phase 3 Results for New Fixed Oral Dose Anticoagulant Presented at 48th Annual Meeting of the American Society of Hematology
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Georgetown University Hospital First to Implant Patient with GORE PROPATEN Vascular Graft in the U.S. since Its FDA Clearance
Devices
 HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Nov 2006
FDA Clears GORE PROPATEN Vascular Graft
Devices FDA
 HSMN NewsFeed - 9 Nov 2006
Spire Introduces New Clot-Resistant Dialysis Catheter at ASN Renal Week 2006 Conference; Spire Biomedical Offers FDA-Approved Decathlon Gold(TM) Coated Catheter
Devices
 HSMN NewsFeed - 4 Oct 2006
Kyowa Hakko Grants Keryx Biopharmaceuticals Exclusive Rights to UCN-01, a Novel, Anticancer Agent in Phase II Clinical Development
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Oct 2006
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Generics
 HSMN NewsFeed - 2 Oct 2006
FDA Grants Priority Review for ARIXTRA(R) (fondaparinux sodium) in the Treatment of Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Sep 2006
Spire Receives FDA Clearance to Market Nanocrystalline, Silver Coated, Long-Term Dialysis Catheters
Devices FDA
 HSMN NewsFeed - 7 Sep 2006
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 2 Jun 2006
ATryn(R) Receives CHMP Recommendation to Grant Market Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jun 2006
Nuvelo Announces Completion of Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 May 2006
Clinical Trial Data from NMT Medical's BEST Trial Presented at EuroPCR
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 190

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 190 additional stories matching:
heparin
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!